Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
<< anterior 21 a 40 de 150 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Leucht S, Tardy M, Komosa K, Heres S, Kissling W, Salanti G, Davis JM. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 2012;379:2063-71. [Ref.ID 93128]
22. Cita con resumen
Anónimo. Antipsychotics in children and adolescents: cardiometabolic reactions. Canada. WHO Drug Information 2012;26:29-30. [Ref.ID 92558]
23. Cita con resumen
24.Tiene citas relacionadas Cita con resumen
McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012;379:721-8. [Ref.ID 92410]
25.Tiene citas relacionadas
Malhi GS, Berk M. Is the safety of lithium no longer in the balance?. Lancet 2012;379:690-2. [Ref.ID 92409]
26.
Anónimo. Monitoring unwanted effects of antipsychotics. Drug Ther Bull 2011;49:117-20. [Ref.ID 91992]
27. Cita con resumen
Anónimo. Side effects have women stopping aromatase inhibitors early. DIA Daily 2011:12 de diciembre. [Ref.ID 91681]
28. Cita con resumen
Anónimo. Prises de poids d'origine médicamenteuse. Prescrire 2011;31:748-52. [Ref.ID 91601]
29. Cita con resumen
Gross JL, Kramer CK, Leitao CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azavedo MJ, for the Diabetes and Endocrinology Meta-analysis Group (DEMA). Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med 2011;154:672-9. [Ref.ID 91283]
30. Cita con resumen
Maher AR, Maglione M, Bagley S, Suttorp M, Hu J-H, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults. A systematic review and meta-analysis. JAMA 2011;306:1359-69. [Ref.ID 91219]
31. Cita con resumen
Lambert T. Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber 2011;34:97-9. [Ref.ID 91100]
33.Enlace a cita original Cita con resumen
Gross J, Kramer CK, Leltao CB, Hawkins N, Viana LV, Schaan VD, Pinto LC, Rodriguez TC, Azevedo MJ. Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med 2011;154:672-9. [Ref.ID 90729]
34.Enlace a cita original
Praharaj SK, Jana AK, Goyal N, Sinha VK. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis. Br J Clin Pharmacol 2011;71:377-82. [Ref.ID 90430]
35. Cita con resumen
Anónimo. Saxagliptin/metformin (Kombiglyze XR) for type 2 diabetes. Med Lett Drugs Ther 2011;53:21-2. [Ref.ID 90335]
39.Tiene citas relacionadas
Coleman CI, Phung OJ, Scholle JM. Adding noninsulin antidiabetic drugs to metformin therapy for type 2 diabetes. JAMA 2010;304:406-7. [Ref.ID 88951]
40.Tiene citas relacionadas
Rodbard HW, Jellinger PS. Adding noninsulin antidiabetic drugs to metformin therapy for type 2 diabetes. JAMA 2010;304:405-6. [Ref.ID 88950]
Seleccionar todas
 
<< anterior 21 a 40 de 150 siguiente >>